|MDACC Study No:||2013-1041 (clinicaltrials.gov NCT No: NCT02117219)|
|Title:||A Phase 1 Study to Evaluate the Safety and Tolerability of MEDI4736 in Subjects with Myelodysplastic Syndrome after Treatment with Hypomethylating Agents|
|Principal Investigator:||Guillermo Garcia-Manero|
|Study Description:||The goal of this clinical research study is to find the dose of MEDI4736 that |
researchers think will work best in patients with MDS. The safety of this drug
will also be studied.